Island Pharmaceuticals

Back to Search

Island Pharmaceuticals

Categories

Core Members

Core Membership

About

Island Pharmaceuticals is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. We have a lead asset – ISLA-101 - that was initially developed by our wholly owned subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases.

Membership Type

Core Membership

Powered By GrowthZone